CP and ovarian carcinoma: Strikingly, we reported that DIPH does not decrease DNA platination as observed in the normal tissue, but rather significantly increases it (Fig. 2; Table S3) and sensitized it to CP in primarily platinum‐resistant ovarian cancer cells (Fig. 3).